Home2019-04-16T00:42:16+00:00

View Our Latest News

ACCESS

Events

Events

Learn More

News

News

Learn More

Pipeline

Pipeline

Learn More

Patients

Patients

Learn More

Vision is our Mission

Latest News

  • IVERIC bio to Present at the Wedbush PacGrow Healthcare Conference
    NEW YORK --(BUSINESS WIRE)--Aug. 7, 2019-- IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Glenn P. Sblendorio , Chief Executive Officer and President of IVERIC bio, will present an overview of the Company at the Wedbush PacGrow Healthcare Conference in New York on Wednesday, August 14, 2019
  • IVERIC bio Reports Second Quarter 2019 Financial and Operating Results
    - Company Continues to Expand its Gene Therapy Portfolio with the Addition of miniUSH2A Program - - Company to Host First Gene Therapy R&D Investor Day on September 13, 2019 - - Conference Call and Webcast Today, August 1, 2019 , at 8:00 a.m. ET - NEW YORK --(BUSINESS WIRE)--Aug.
  • IVERIC bio to Report Second Quarter 2019 Financial Results and Host Conference Call on Thursday, August 1, 2019
    NEW YORK --(BUSINESS WIRE)--Jul. 25, 2019-- IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its second quarter 2019 financial and operating results on Thursday, August 1, 2019 . Following the announcement, IVERIC bio’s management team will host a live conference call and webcast
VIEW ALL ARTICLES

Contact Us

For more information, contact us.

READ MORE